Metrics & diligence

Freedom to operate

Whether a company can commercialize without infringing others' patents, a sharper risk in deeptech given dense portfolios held by large incumbents.

← All terms

Freedom to operate is the ability to make, use and sell a product without infringing the valid intellectual-property rights of others. It is distinct from owning IP: a company can hold a strong patent on its own invention and still infringe a third party’s patent on a technique it must use to ship. FTO is assessed by searching the relevant patent landscape for claims that read on the intended product, then clearing them by designing around, licensing, or forming a view that the claims are invalid or do not apply.

In hardware-heavy deeptech the risk is elevated because the patent landscape is both dense and foundational. Large incumbents and research institutions have spent decades filing across core device architectures, materials, control methods, algorithms and fabrication, so a startup’s core approach may sit close to, or squarely within, existing claims. The danger is asymmetric: the time to discover an infringement problem is before scaling, not after a product is in market and an incumbent has both the patent and the lawyers.

For an investor, FTO is a specific diligence line, not a footnote to “we have patents”. The questions: has a freedom-to-operate analysis been done, by competent counsel, and what did it surface; are the blocking patents licensed, designed around, or genuinely absent; and how exposed is the company to the big portfolio holders in its field. A clean, documented FTO position is a real asset in deep tech; its absence is a latent liability that can surface at the worst possible moment, typically when the company is finally large enough to be worth suing.

In Canada

Many Canadian deeptech companies begin as university spin-outs, and the IP question is twofold: whether the licence or assignment from the institution is clean, and whether the product can ship without crossing third-party patents, which is FTO proper. Because the commercial market for most Canadian deeptech is the US, the analysis has to cover US patents, not just Canadian filings. US funds arriving at Series A or B routinely commission their own FTO reads, so a documented analysis, with blocking patents licensed or designed around, shortens diligence and protects the price. An FTO opinion is also ordinary due-diligence material for a cross-border acquirer, so the file built now gets reused at exit.

Related terms

Updated July 9, 2026. Open this term in the app →